Revenue grew 5.7% year-over-year with record organic orders and strong performance in Advanced Imaging and Pharmaceutical Diagnostics, while Patient Care Solutions declined. Net income margin improved, and full-year guidance was reaffirmed. Free cash flow and share repurchases increased.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.